Lung cancer is the second most common cancer in men and women, and is the
leading cause of cancer related death. In industrialized countries the mortality rate
of lung cancer is higher than the mortality rate of breast, colorectal and prostate
cancer combined 1. When lung cancer is diagnosed at an early stage patients are
considered to have the best overall survival rate 2. Unfortunately, only a minority of
patients is currently diagnosed at a curable stage of disease. The lack of specific
symptoms at an early stage of the disease, the rapid growth of tumor cells and the
metastatic behavior of lung tumors are the main reasons for a diagnosis at an
advanced stage.
Non-small-cell lung cancer (NSCLC) can be divided into three major histological
subtypes: squamouscell carcinoma, adenocarcinoma, and large-cell carcinoma 3.
Eighty-five percent of the lung cancer patients are diagnosed with NSCLC, and
75% of the patients are diagnosed with an incurable stage IIIB or IV disease 4, 5.
Fifteen percent of the lung cancer patients have small-cell-lung cancer (SCLC)
and the 5-year survival for them is even lower than for NSCLC 6.
Whereas originally smoking is at the root of all types of lung cancer, the incidence
of lung cancer in never smokers increases 7. Smoking is most strongly linked with
SCLC and squamous-cell carcinoma 8, 9, although after the introduction of filter
cigarets an increased incidence of adenocarcinomas was observed 10. This
resulted in a change in ratio of adenocarcinomas-squamous cell carcinomas
towards adenocarcinomas 8, 11. In some countries squamous cell carcinoma is still
the most common histological type of lung cancer in male patients, e.g. France
(41%) and United Kingdom (40%). In other countries adenocarcinoma is the most
common type e.g. USA and Canada 12. In patients without a smoking history
adenocarcinoma is most common 13-16.
Despite new insights and improved medical treatments, lung cancer remains the
type of cancer with the highest mortality. Additional studies are needed to improve
detection of lung cancer in an early (pre)malignant stage to improve survival.
Improved pretreatment staging of lung cancer is necessary to prevent under- or
over treatment. Furthermore a better understanding of tumor behavior improves
treatment modalities.
In this introduction the histological subtypes of lung cancer, the microenvironment
of lung cancer and systemic treatment modalities are described. Furthermore
several imaging techniques to analyze the microenvironment of lung cancer tissue
are discussed.
http://repub.eur.nl/res/pub/19596/100528_Leest%2C%20Kornelis%20Harm%20van%20der-%20bewerkt.pdf
http://repub.eur.nl/res/pub/19596/100528_Leest%2C%20Kornelis%20Harm%20van%20der-%20bewerkt.pdf
No comments:
Post a Comment